Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen
-
Z Evid Fortbild Qual Gesundhwes · Jan 2014
Biography Historical Article Classical Article[Health resort fraud. 1907].
-
Z Evid Fortbild Qual Gesundhwes · Jan 2014
Review[Methods of patient involvement in the development of guidelines - a systematic review].
Involving patients or patient-representatives in the development of guidelines is widely recommended. The expected benefits of patient involvement include an increase in the relevance and acceptability of the guidelines. So far there has been no systematic review of patient involvement in the development process of the German AMWF S3 and nursing guidelines and no description of the recommendations made by guideline-developing organisations and the scientific literature concerning the methods of patient involvement. ⋯ In the German AMWF and nursing guidelines, patient involvement is currently not an established standard. This could be improved by including mandatory rules for patient involvement in the manuals for guideline development. More research is needed on the effects of patient involvement on the content and applicability of guidelines.
-
Z Evid Fortbild Qual Gesundhwes · Jan 2014
The NICE process for developing quality standards and indicators.
This paper describes the core principles and processes used by the National Institute for Health and Care Excellence (NICE) to develop quality standards and quality indicators from evidence based guidelines.
-
Z Evid Fortbild Qual Gesundhwes · Jan 2014
Comparative StudyRevolution then evolution: the advance of health economic evaluation in Australia.
All governments face immense challenges in providing affordable healthcare for their citizens, and the diffusion of novel health technologies is a key driver of growth in expenditure for many. Although important methodological and process variations exist around the world, health economic evaluation is increasingly seen as an important tool to support decision-making around the introduction of new health technologies, interventions and programmes in countries of varying stages of economic development. In Australia, the assessment of the comparative cost-effectiveness of new medicines proposed for subsidy under the country's national drug subsidy programme, the Pharmaceutical Benefits Scheme, was introduced in the late 1980s and became mandatory in 1993, making Australia the first country to introduce such a requirement nationally. Since then the use of health economic evaluation has expanded and been applied to support decision-making across a broader range of health technologies, as well as to programmes in public health.
-
The American Board of Internal Medicine (ABIM) Foundation launched the Choosing Wisely campaign in 2012 and until today convinced more than 50 US specialist societies to develop lists of interventions that may not improve people's health but are potentially harmful. We suggest combining these new efforts with the already existing efforts in clinical practice guideline development. Existing clinical practice guidelines facilitate a more participatory and evidence-based approach to the development of top 5 lists. In return, adding top 5 lists (for overuse and underuse) to existing clinical practice guidelines nicely addresses a neglected dimension to clinical practice guideline development, namely explicit information on which Do or Don't do recommendations are frequently disregarded in practice.